Orthofix Medical Inc. provided net sales guidance for the year ended December 31, 2022. For the year, company expects net sales to be $475.0 million to $490.0 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.62 USD | -0.59% |
|
+2.02% | -6.31% |
Jun. 18 | Orthofix Medical Inc. Appoints Aviva Mcpherron as President of Global Operations and Quality | CI |
Jun. 11 | Orthofix Names Julie Dewey Chief Investor Relations and Communications Officer | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.31% | 477M | |
-4.16% | 185B | |
-1.36% | 105B | |
-2.38% | 68.9B | |
+15.76% | 46.41B | |
-6.14% | 46.16B | |
+5.36% | 40.75B | |
+20.16% | 31.11B | |
+11.60% | 24.26B | |
-5.76% | 23.94B |
- Stock Market
- Equities
- OFIX Stock
- News Orthofix Medical Inc.
- Orthofix Medical Inc. Provides Net Sales Guidance for the Year Ended December 31, 2022